Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000080233 | SCV000112128 | benign | not specified | 2012-11-02 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000080233 | SCV000309643 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000710125 | SCV000512915 | benign | not provided | 2019-04-19 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 25312915, 22995991, 31862442, 20981092, 17698709, 27884173, 21522182, 25214167) |
Athena Diagnostics | RCV000710125 | SCV000613180 | benign | not provided | 2017-10-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000550203 | SCV000649604 | benign | Qualitative or quantitative defects of dysferlin | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000550203 | SCV001300835 | uncertain significance | Qualitative or quantitative defects of dysferlin | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000080233 | SCV002050942 | likely benign | not specified | 2021-12-10 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000710125 | SCV002544046 | benign | not provided | 2024-07-01 | criteria provided, single submitter | clinical testing | DYSF: BS1, BS2 |
Genetic Services Laboratory, |
RCV000080233 | SCV000151013 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000080233 | SCV001743867 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000710125 | SCV001797971 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000080233 | SCV001929504 | benign | not specified | no assertion criteria provided | clinical testing | ||
Natera, |
RCV001835673 | SCV002079800 | benign | Autosomal recessive limb-girdle muscular dystrophy type 2B | 2019-11-14 | no assertion criteria provided | clinical testing |